In drug discovery, researchers think a lot about how tightly a small molecule binds to its target. For a long time, drug developers have considered tightly binding compounds better, more promising ...
When a drug molecule binds to its target protein, it stays bound for some time before eventually unbinding the target. The actual time how long a drug molecule resides bound to its target varies among ...
A new study helps to explain what defines how long a drug molecule stays bound to its target. A new study from the University of Eastern Finland and the University of Tübingen helps to explain what ...
On-target residence times are rarely optimized during drug development programmes, but they probably have a crucial role in determining efficacy as well as off-target and on-target adverse effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results